Low dose IL-2 in patients with steroid-dependent dysimmune manifestations associated with myelodysplastic syndromes: a three-case report.
Marion CorfmatChristophe WillekensJulien VinitGuillaume BussonePierre FenauxOlivier FainDavid KlatzmannArsenne MekinianThibault Comontnull nullPublished in: Rheumatology (Oxford, England) (2021)
Our results support the investigation of ld-IL2 in MDS associated with immune disorders in controlled clinical studies.
Keyphrases